Predict your next investment

HEALTHCARE | Biotechnology

See what CB Insights has to offer

Founded Year

2018

Stage

Corporate Majority | Acquired

About Perception Neuroscience

Perception Neuroscience focuses on the development of Arketamine therapies in neuropsychiatric disorders. The main focus of Perception Neuroscience's clinical research activities is the NMDA antagonist arketamine (PCN 101), an isomer of ketamine.

Perception Neuroscience Headquarter Location

New York, New York,

United States

Latest Perception Neuroscience News

In the clinic for Sept. 15, 2021

Sep 16, 2021

Clinical updates, including trial initiations, enrollment status and data readouts and publications: AB Science, Astellas, Beckley Psytech, Calcimedica, Cstone, Emalex, Enzychem, Eqrx, Intrabio, Janssen, Jemincare, KSQ, Medicenna, Nimbus, NLS, Perception Neuroscience, Pharming, Redhill, Rocket, Valneva.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Perception Neuroscience

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Perception Neuroscience is included in 2 Expert Collections, including Psychedelics.

P

Psychedelics

225 items

N

Neuroscience

2,144 items

Companies developing products that monitor, analyze, protect, or otherwise influence the structure/function of the nervous system.

Perception Neuroscience Patents

Perception Neuroscience has filed 1 patent.

The 3 most popular patent topics include:

  • Abnormal psychology
  • Addiction
  • Drug rehabilitation
patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/3/2019

Psychiatric diagnosis, Substance dependence, Abnormal psychology, Drug rehabilitation, Addiction

Application

Application Date

5/3/2019

Grant Date

Title

Related Topics

Psychiatric diagnosis, Substance dependence, Abnormal psychology, Drug rehabilitation, Addiction

Status

Application

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.